Pontifax (China) IV L.P.
Related Filers (14)
- Pontifax (Cayman) IV L.P. (15)
- Pontifax (Israel) IV, L.P. (15)
- Pontifax Management 4 G.P. (2015) Ltd. (13)
- Pontifax IV GP L.P. (8)
- Eloxx Pharmaceuticals, Inc. (8)
- Pontifax Late Stage Fund L.P. (7)
- Pontifax Late Stage GP Ltd. (7)
- Keros Therapeutics, Inc. (7)
- Pontifax (Israel) III, L.P. (2)
- Pontifax (Cayman) III, L.P. (2)
- Pontifax Management Fund III L.P. (2)
- Pontifax Management III G.P. (2011) Ltd. (2)
- Nussbaum Ran (1)
- Kariv Tomer (1)
- Show More ...
Ownership (15)
4
Wednesday, 11/30/2022
Keros Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3/A
Wednesday, 11/30/2022
Keros Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 5/17/2021
Eloxx Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/19/2020
Keros Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/19/2020
Keros Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/19/2020
Keros Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/22/2020
Eloxx Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/13/2020
Keros Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 4/7/2020
Keros Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 6/26/2019
Eloxx Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/29/2019
Eloxx Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/19/2018
Eloxx Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/1/2018
Eloxx Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/23/2018
Eloxx Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 12/29/2017
Eloxx Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities